Clear Street’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.5K Sell
287,916
-9,800
-3% -$763 ﹤0.01% 1220
2026
Q2
$23.8K Buy
297,716
+154,745
+108% +$13.2K ﹤0.01% 1099
2026
Q1
$11.4K Buy
142,971
+115,712
+424% +$13.1K ﹤0.01% 942
2025
Q4
$3.82K Buy
+27,259
New +$3.89K ﹤0.01% 830

Other funds holding DMIIR

Clear Street's DMIIR Position: Q3 2026 in Review

Clear Street reduced its Drugs Made In America Acquisition II Corp Right (DMIIR) stake by 3.3% in Q3 2026, selling an estimated $763 and leaving 287,916 shares worth $18.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1220.

Clear Street first reported a position in DMIIR in Q4 2025 and has held it in 4 quarters since. The position peaked at $23.8K in Q2 2026. 64 funds tracked by Wall St. Rank hold DMIIR as of Q3 2026.

  • Clear Street held 287,916 shares of Drugs Made In America Acquisition II Corp Right worth $18.5K as of Q3 2026.
  • Clear Street sold 9,800 Drugs Made In America Acquisition II Corp Right shares in Q3 2026, an estimated $763.
  • Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of Clear Street's portfolio in Q3 2026, its #1220 holding.
  • Clear Street first reported a position in Drugs Made In America Acquisition II Corp Right in Q4 2025 and has held it in 4 quarters since.
  • Clear Street's Drugs Made In America Acquisition II Corp Right position peaked at $23.8K in Q2 2026.
  • 64 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q3 2026.

Based on Clear Street's 13F filing for Q3 2026, filed 16 Nov 2026.